$ODYS
Odysight.ai Inc. Stock $odys

$odys Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223009276 Filed on March 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$303.0K	$159.0K	$665.0K
YoY Change	15050.0%	140.91%	71.83%
Cost Of Revenue	$550.0K	$352.0K	$1.631M
YoY Change	90.97%	22.65%	47.2%
Gross Profit	-$247.0K	-$193.0K	-$966.0K
YoY Change	-13.64%	-12.67%	33.98%
Gross Profit Margin	-81.52%	-121.38%	-145.26%
Selling, General & Admin	$1.134M	$397.0K	$4.276M
YoY Change	-25.83%	-80.01%	-33.07%
% of Gross Profit
Research & Development	$1.398M	$1.174M	$4.197M
YoY Change	46.54%	80.06%	109.64%
% of Gross Profit
Depreciation & Amortization	$155.0K	$91.00K	$251.0K
YoY Change	210.0%	78.43%	120.18%
% of Gross Profit
Operating Expenses	$2.532M	$1.564M	$8.473M
YoY Change	2.3%	-40.6%	1.07%
Operating Profit	-$2.779M	-$1.757M	-$9.439M
YoY Change	0.65%	-38.44%	3.68%
Interest Expense	$86.00K	$93.00K	-$59.00K
YoY Change	-418.52%	-24.39%	-150.43%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.686M	-$1.664M	-$9.468M
YoY Change	-3.66%	-39.07%	5.35%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$2.686M	-$1.664M	-$9.468M
YoY Change	-3.66%	-39.07%	5.35%
Net Earnings / Revenue	-886.47%	-1046.54%	-1423.76%
Basic Earnings Per Share	-$0.37		-$1.33
Diluted Earnings Per Share	-$0.37	-$0.23	-$1.33
COMMON SHARES
Basic Shares Outstanding	10.43M shares	7.122M shares	7.122M shares
Diluted Shares Outstanding	7.276K shares		7.122K shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.59M	$13.15M	$13.15M
YoY Change	27.28%	-32.91%	-32.91%
Cash & Equivalents	$9.583M	$10.10M	$10.10M
Short-Term Investments	$15.01M	$3.047M	$3.047M
Other Short-Term Assets	$564.0K	$281.0K	$281.0K
YoY Change	35.58%	-36.57%	-36.57%
Inventory	$693.0K	$630.0K	$630.0K
Prepaid Expenses
Receivables	$61.00K	$60.00K	$60.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.91M	$14.12M	$14.12M
YoY Change	29.93%	-30.16%	-30.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$508.0K	$648.0K	$955.0K
YoY Change	-58.29%	-17.03%	-24.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$268.0K	$328.0K	$328.0K
YoY Change	-31.28%	-17.17%	-17.17%
Total Long-Term Assets	$2.557M	$2.778M	$2.778M
YoY Change	-22.11%	-16.68%	-16.68%
TOTAL ASSETS
Total Short-Term Assets	$25.91M	$14.12M	$14.12M
Total Long-Term Assets	$2.557M	$2.778M	$2.778M
Total Assets	$28.46M	$16.90M	$16.90M
YoY Change	22.57%	-28.25%	-28.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$365.0K	$297.0K	$297.0K
YoY Change	60.79%	188.35%	188.35%
Accrued Expenses	$943.0K	$778.0K	$778.0K
YoY Change	12.4%	-5.24%	-5.24%
Deferred Revenue	$1.304M	$1.426M
YoY Change		312.14%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.620M	$2.559M	$2.559M
YoY Change	11.87%	95.49%	95.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.468M	$2.550M	$2.550M
YoY Change	-24.73%	-2.71%	-2.71%
Total Long-Term Liabilities	$2.468M	$2.550M	$2.550M
YoY Change	-24.73%	-2.71%	-2.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.620M	$2.559M	$2.559M
Total Long-Term Liabilities	$2.468M	$2.550M	$2.550M
Total Liabilities	$5.088M	$5.109M	$5.109M
YoY Change	-9.48%	30.0%	30.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.45M	-$24.76M
YoY Change		61.91%
Common Stock	$50.82M	$36.55M
YoY Change		4.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.38M	$11.79M	$11.79M
YoY Change
Total Liabilities & Shareholders Equity	$28.46M	$16.90M	$16.90M
YoY Change	22.57%	-28.25%	-28.25%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.686M	-$1.664M	-$9.468M
YoY Change	-3.66%	-39.07%	5.35%
Depreciation, Depletion And Amortization	$155.0K	$91.00K	$251.0K
YoY Change	210.0%	78.43%	120.18%
Cash From Operating Activities	-$2.474M	-$1.988M	-$6.095M
YoY Change	1004.46%	68.19%	3.55%
INVESTING ACTIVITIES
Capital Expenditures	$15.00K	$31.00K	$118.0K
YoY Change	-162.5%	-127.68%	-119.83%
Acquisitions
YoY Change
Other Investing Activities	-$12.00M	$9.500M	$8.000M
YoY Change		-186.36%	-172.73%
Cash From Investing Activities	-$12.02M	$9.469M	$7.882M
YoY Change	49962.5%	-185.21%	-167.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$13.98M	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-$2.474M	-1.988M	-$6.095M
Cash From Investing Activities	-$12.02M	9.469M	$7.882M
Cash From Financing Activities	$13.98M	0.000
Net Change In Cash	-$512.0K	7.481M	$1.787M
YoY Change		-166.43%	-64.81%
FREE CASH FLOW
Cash From Operating Activities	-$2.474M	-$1.988M	-$6.095M
Capital Expenditures	$15.00K	$31.00K	$118.0K
Free Cash Flow	-$2.489M	-$2.019M	-$6.213M
YoY Change	1144.5%	88.69%	17.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001577445
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	SCTC	Round Up Shares Due To Reverse Stock Split RoundUpSharesDueToReverseStockSplit		usd
CY2021	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability		usd
CY2021	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits		usd
CY2022	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	SCTC	Issuance Expenses IssuanceExpenses		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	SCTC	Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers		usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24762000	usd
CY2022Q4	SCTC	Internal Revenue Service InternalRevenueService		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase		usd
CY2021	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts		usd
CY2021	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-188920
CY2022	dei	Entity Registrant Name EntityRegistrantName	SCOUTCAM INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-4257143
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Suite 7A and 3B
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Industrial Park
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	P.O. Box 3030
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Omer
CY2022	dei	Entity Address Country EntityAddressCountry	IL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	8496500
CY2022	dei	City Area Code CityAreaCode	+972
CY2022	dei	Local Phone Number LocalPhoneNumber	73 370-4691
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	19220000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10432518	shares
CY2022	dei	Auditor Firm AuditorFirmId	1197
CY2022	dei	Auditor Name AuditorName	Brightman Almagor Zohar & Co.
CY2022	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10099000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8581000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3047000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	11013000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	630000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	167000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	281000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	443000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14117000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20212000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1495000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1675000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	781000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	307000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	482000	usd
CY2022Q4	SCTC	Severance Pay Asset SeverancePayAsset	328000	usd
CY2021Q4	SCTC	Severance Pay Asset SeverancePayAsset	396000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2778000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3334000	usd
CY2022Q4	us-gaap	Assets Assets	16895000	usd
CY2021Q4	us-gaap	Assets Assets	23546000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	297000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	103000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1426000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	346000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	256000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	365000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	355000	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	58000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	39000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	214000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	210000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2559000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1309000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2218000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2074000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	203000	usd
CY2022Q4	SCTC	Liability For Severance Pay LiabilityForSeverancePay	268000	usd
CY2021Q4	SCTC	Liability For Severance Pay LiabilityForSeverancePay	344000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2550000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2621000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5109000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3930000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7121737	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7121737	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7121737	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7121737	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36541000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	34903000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24762000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15294000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16895000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23546000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	665000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	387000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1631000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1108000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-966000	usd
CY2021	us-gaap	Gross Profit GrossProfit	-721000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4197000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2002000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	699000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	908000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3577000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5481000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-9439000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-9112000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30000	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	8000	usd
CY2022	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	-59000	usd
CY2021	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	117000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9468000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8987000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9468000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8987000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.44
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7122000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6240000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1638000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9468000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3964000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3964000	usd
CY2021	SCTC	Stock Issued During Period Value Of Shares And Warrants StockIssuedDuringPeriodValueOfSharesAndWarrants	19118000	usd
CY2021	SCTC	Exercise Of Warrants ExerciseOfWarrants	3491000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2030000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8987000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9468000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8987000	usd
CY2022	us-gaap	Depreciation Depreciation	251000	usd
CY2021	us-gaap	Depreciation Depreciation	114000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1638000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2030000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-269000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	130000	usd
CY2022	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability	49000	usd
CY2022	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	8000	usd
CY2021	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	25000	usd
CY2022	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	34000	usd
CY2021	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	13000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	52000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	463000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-77000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-233000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	20000	usd
CY2022	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	261000	usd
CY2021	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	-43000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-162000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	126000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	194000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	24000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-180000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	545000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1224000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1572000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	10000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-19000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-86000	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4000	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	65000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6095000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5886000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	595000	usd
CY2022	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits	14500000	usd
CY2022	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	6500000	usd
CY2021	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	11000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7882000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11595000	usd
CY2021	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants	19118000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3491000	usd
CY2021	SCTC	Issuance Expenses IssuanceExpenses	50000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22559000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1787000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5078000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8581000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3373000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-269000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	130000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10099000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8581000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	155000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	524000	usd
CY2021	SCTC	Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers	31000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zsYalrco8Ux1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_825_z79SxFmFVUhe">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ScoutCam Inc. (the “Company”), formerly known as Intellisense Solutions Inc., (“Intellisense”), was incorporated under the laws of the State of Nevada on March 22, 2013. Prior to the closing of the Exchange Agreement (as defined below), the Company was a non-operating “shell company”.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly-owned subsidiary, ScoutCam Ltd. (“ScoutCam”), was formed in the State of Israel on January 3, 2019, as a wholly-owned subsidiary of Medigus Ltd. (“Medigus”), an Israeli company traded on the Nasdaq Capital Market, and commenced operations on March 1, 2019. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, Medigus and ScoutCam consummated an asset transfer agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to ScoutCam. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 30, 2019, Intellisense and Medigus consummated a securities exchange agreement (the “Exchange Agreement”), pursuant to which Medigus delivered 100% of its holdings in ScoutCam to Intellisense in exchange for shares of Intellisense’s common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the consummation of the Exchange Agreement. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, Medigus beneficially owned 27.02% of the Company’s outstanding common stock. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through ScoutCam, is engaged in the development, production and marketing of innovative Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for critical systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries. Some of the Company’s products utilize our micro visualization technology in medical devices for complex and minimally invasive medical procedures. Company’s technology includes proven video technologies and products amalgamated into a first-of-its-kind, FDA-cleared minimally invasive surgical device. The Company’s video-based sensors, embedded software and AI algorithms are being deployed in hard-to-reach locations and harsh environments across a variety of PdM and CBM use cases. The Company’s solution allows maintenance and operations teams visibility into areas which are inaccessible under normal circumstances, or where the operating ambience otherwise is not suitable for continuous real-time monitoring’ and has various applications which have relevancy in wide range of industry segments, that utilize complicated mechanics requiring ongoing monitoring and predictive maintenance applications. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCOUTCAM INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL</b> (continued)<b>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 9, 2021, the Company amended its Articles of Incorporation to effect a <span id="xdx_900_eus-gaap--StockholdersEquityReverseStockSplit_c20210808__20210809_zPI7HM1fCr7a" title="Stockholders' equity, reverse stock split">nine-to-one</span> reverse stock split of its outstanding Common Stock.</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">As a result of the reverse stock split, every nine shares of the Company’s outstanding Common Stock were combined and reclassified into one share of the Company’s Common Stock. No fractional shares were issued in connection with or following the reverse split. The amount of authorized capital of the Company’s Common Stock and par value of such shares remained unchanged.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All share, stock option and per share information in these consolidated financial statements have been adjusted to reflect the reverse stock split on a retroactive basis.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since incorporation of ScoutCam and through December 31, 2022, the Company accumulated a deficit of approximately $<span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pn3n3_dxL_c20221231_zAwAVp3P6jOh" title="::XDX::-24762"><span style="-sec-ix-hidden: xdx2ixbrl0416">25 </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources as of December 31, 2022 as well as its proceeds from issuance of common stock and warrants in the private offering as detailed in Note 14, will allow the Company to fund its operating plan through at least the next 12 months. However, the Company expects to continue to incur significant research and development and other costs related to its ongoing operations and in order to continue its future operations, the Company will need to obtain additional funding until becoming profitable.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCOUTCAM INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify; text-indent: -49.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	nine-to-one
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zpciYLHYkDXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z6iqiCJacFki">Use of estimates</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates its assumptions on an ongoing basis, including those related to contingencies and inventory impairment, as well as estimates used in applying its revenue recognition policy. Actual results may differ from these estimates.</span></p>
CY2022	SCTC	Monthly Salary Percentage MonthlySalaryPercentage	0.0833	pure
CY2020	SCTC	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P6Y2M23D
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.04	pure
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P12M
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	438000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	99000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	148000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	66000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	630000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	167000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2446000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	648712	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.09
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	132207	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.34
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1253554	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.31
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1152000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1034000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	504000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	253000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	781000	usd
CY2022	us-gaap	Depreciation Depreciation	251000	usd
CY2021	us-gaap	Depreciation Depreciation	114000	usd
CY2021Q4	SCTC	Internal Revenue Service InternalRevenueService	40000	usd
CY2022Q4	SCTC	Accrued Expenses Current AccruedExpensesCurrent	214000	usd
CY2021Q4	SCTC	Accrued Expenses Current AccruedExpensesCurrent	170000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	214000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	210000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5884000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	479000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.50
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26295000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	15582000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6069000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3595000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	6069000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	3595000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6069000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26295000	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	58000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	39000	usd
CY2021	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	82000	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	117000	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	37000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	737049	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	172514	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.57
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1560040	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.64
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M1D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2116000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	838994	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.10
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y2M26D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1595000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.5
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	90000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	127000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	665000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	387000	usd
CY2022	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	665000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	387000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1675000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2420000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1675000	usd
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1130000	usd
CY2021	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	545000	usd
CY2022	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts	-180000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1675000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2420000	usd
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	848000	usd
CY2022	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales	1613000	usd
CY2021	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales	1641000	usd
CY2022	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-389000	usd
CY2021	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-69000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2420000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3644000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	307000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	263000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	482000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	459000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	3000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	264000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	202000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	261000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	202000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M2D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M3D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	206000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	54000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	16000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	276000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	263000	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	2034000	usd
CY2021	us-gaap	Salaries And Wages SalariesAndWages	894000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	576000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	257000	usd
CY2022	SCTC	Materials And Subcontractors MaterialsAndSubcontractors	1030000	usd
CY2021	SCTC	Materials And Subcontractors MaterialsAndSubcontractors	655000	usd
CY2022	us-gaap	Depreciation Nonproduction DepreciationNonproduction	163000	usd
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	39000	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	73000	usd
CY2022	SCTC	Vehicle Expenses VehicleExpenses	75000	usd
CY2021	SCTC	Vehicle Expenses VehicleExpenses	26000	usd
CY2022	SCTC	Rent And Maintenance And Other Expenses RentAndMaintenanceAndOtherExpenses	246000	usd
CY2021	SCTC	Rent And Maintenance And Other Expenses RentAndMaintenanceAndOtherExpenses	131000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4197000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2002000	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1027000	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1144000	usd
CY2022	SCTC	Share Based Compensation Included In General And Administartive Expenses ShareBasedCompensationIncludedInGeneralAndAdministartiveExpenses	903000	usd
CY2021	SCTC	Share Based Compensation Included In General And Administartive Expenses ShareBasedCompensationIncludedInGeneralAndAdministartiveExpenses	1483000	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	859000	usd
CY2021	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1193000	usd
CY2022	SCTC	Patents Patents	292000	usd
CY2021	SCTC	Patents Patents	798000	usd
CY2022	SCTC	Depreciation Included In General And Administartive Expenses DepreciationIncludedInGeneralAndAdministartiveExpenses	34000	usd
CY2021	SCTC	Depreciation Included In General And Administartive Expenses DepreciationIncludedInGeneralAndAdministartiveExpenses	29000	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	337000	usd
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	386000	usd
CY2022	SCTC	Vehicle Expenses Included In General And Administartive Expenses VehicleExpensesIncludedInGeneralAndAdministartiveExpenses	73000	usd
CY2021	SCTC	Vehicle Expenses Included In General And Administartive Expenses VehicleExpensesIncludedInGeneralAndAdministartiveExpenses	99000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	181000	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	120000	usd
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-129000	usd
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	229000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3577000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5481000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-009276-index-headers.html	Edgar Link	pending
0001493152-23-009276-index.html	Edgar Link	pending
0001493152-23-009276.txt	Edgar Link	pending
0001493152-23-009276-xbrl.zip	Edgar Link	pending
ex10-23.htm	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex3-2_1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
report_001.jpg	Edgar Link	pending
sctc-20221231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sctc-20221231_cal.xml	Edgar Link	unprocessable
sctc-20221231_lab.xml	Edgar Link	unprocessable
sctc-20221231_def.xml	Edgar Link	unprocessable
sctc-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ODYS
Odysight.ai Inc. Stock $odys

2023 Q1 Form 10-K Financial Statement

#000149315223009276 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS Odysight.ai Inc. Stock $odys

2023 Q1 Form 10-K Financial Statement

#000149315223009276 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS
Odysight.ai Inc. Stock $odys